# Therapeutic Treatment of Amyotrophic Lateral Sclerosis

> **NCT02881476** · PHASE1 · UNKNOWN · sponsor: **University of Warmia and Mazury** · enrollment: 30 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** Biological: Cell-based therapy

## Key facts

- **NCT ID:** NCT02881476
- **Lead sponsor:** University of Warmia and Mazury
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881476, "Therapeutic Treatment of Amyotrophic Lateral Sclerosis". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT02881476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*